Sunrest Lifescience Limited (NSE:SUNREST)
India · Delayed Price · Currency is INR 38.50
+3.00 (8.45%)
Oct 6, 2026, 12:37 PM IST
Sunrest Lifescience Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 165 | 159 | 231 | 262 | - | - | |
Market Cap Growth | -18.43% | -31.16% | -11.96% | - | - | - |
Enterprise Value | 404 | 362 | 282 | 303 | - | - |
Last Close Price | 38.50 | 34.49 | 50.10 | 56.90 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 4.01 | 3.86 | 11.50 | 116.07 | - | - |
PS Ratio | 0.23 | 0.22 | 0.69 | 0.89 | - | - |
PB Ratio | 0.56 | 0.54 | 1.07 | 1.85 | - | - |
P/TBV Ratio | 0.81 | 0.78 | 1.42 | 1.85 | - | - |
P/FCF Ratio | - | - | 14.89 | - | - | - |
P/OCF Ratio | - | - | 7.90 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.57 | 0.51 | 0.84 | 1.03 | - | - |
EV/EBITDA Ratio | 3.96 | 3.55 | 9.33 | 33.38 | - | - |
EV/EBIT Ratio | 4.48 | 4.01 | 9.63 | 37.38 | - | - |
EV/FCF Ratio | - | - | 18.21 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.59 | 0.59 | 0.56 | 0.43 | 0.69 | 3.02 |
Debt / EBITDA Ratio | 1.71 | 1.71 | 3.99 | 6.78 | 0.73 | 2.91 |
Debt / FCF Ratio | - | - | 7.78 | - | 1.88 | - |
Net Debt / Equity Ratio | 0.50 | 0.50 | 0.48 | 0.41 | 0.54 | 2.57 |
Net Debt / EBITDA Ratio | 1.44 | 1.44 | 3.41 | 6.46 | 0.58 | 2.48 |
Net Debt / FCF Ratio | -1.94 | -1.94 | 6.66 | -0.40 | 1.49 | -3.01 |
Asset Turnover | 1.09 | 1.09 | 0.80 | 1.41 | 1.66 | 2.39 |
Inventory Turnover | 3.21 | 3.21 | 2.65 | 4.45 | 4.77 | 9.15 |
Quick Ratio | 1.20 | 1.20 | 1.23 | 2.04 | 0.98 | 1.11 |
Current Ratio | 2.12 | 2.12 | 1.73 | 3.31 | 1.41 | 1.42 |
Return on Equity (ROE) | 31.20% | 31.20% | 11.23% | 2.61% | 97.63% | 113.70% |
Return on Assets (ROA) | 8.68% | 8.68% | 4.37% | 2.42% | 11.79% | 5.84% |
Return on Invested Capital (ROIC) | 16.12% | 18.74% | 8.63% | 2.48% | 48.33% | 25.64% |
Return on Capital Employed (ROCE) | 21.50% | 21.50% | 10.60% | 4.60% | 54.80% | 25.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 24.92% | 25.92% | 8.69% | 0.86% | - | - |
FCF Yield | -45.81% | -47.67% | 6.72% | -56.51% | - | - |
Buyback Yield / Dilution | - | - | -29.14% | -10.77% | - | - |